This is a comparative effectiveness study that evaluates the safety effects of 2 types of commercially available electronic prescribing systems. The increasingly widespread adoption of electronic ...

Observational Methods The emergence of comparative effectiveness has led to a renewed interest in the role of observational studies for assessing the benefits and harms of alternative interventions.

Editor’s note: This post is part of a series of several posts related to the 4 th European Forum on Health Policy and Management: Innovation & Implementation, held in Berlin, Germany on January 29 and ...

Quality control by photograph for evaluation of open (OP) and laparoscopic (LAP) colectomy with D3 resection for stage II/III colorectal cancer: Japan Clinical Oncology Group study JCOG 0404. This is ...

The American Recovery and Reinvestment Act of 2009 provided $1.1 billion for comparative effectiveness research (CER). The Patient Protection and Affordable Care Act established the Patient-Centered ...

Clinical trials that are embedded into usual care have the potential to yield outcomes of great relevance to the institutions where they are performed and at the same time to yield information that ...

Peripheral neuropathic pain is one of the most common and debilitating complications of diabetes. Several genes have been shown to be effective in reducing neuropathic pain in animal models of ...

Data sources Sensitive search in seven databases, three grey literature resources and four trial registers. Eligibility criteria Randomised controlled trials evaluating any treatment for PFP with ...

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...

Evaluation of healthcare utilization and costs over 3 years for adults with insulin-requiring diabetes who transition from multiple daily insulin injections to insulin infusion pumps.

The US House of Representatives is considering legislation (HR 485) that would prohibit the use of the quality-adjusted life-year (QALY) and similar measures for coverage and payment determinations ...